Christine Lovly

September 4, 2014

Lung cancer study reveals new drug combination targets

A Vanderbilt lung cancer patient’s exceptional response to different types of therapies spurred research that suggests lung cancer patients with specific gene alterations may benefit from combination therapy that targets two different cancer pathways.

By VUMC News and Communications
July 17, 2014

Lovly’s research bolstered by lung cancer foundation

The LUNGevity Foundation has awarded a 2014 Career Development Award for Translational Research to Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology.

By VUMC News and Communications
July 11, 2013

Lovly lands Damon Runyon cancer research award

Christine Lovly, M.D., Ph.D., assistant professor of Medicine, has received the 2013 Damon Runyon Clinical Investigator Award, which supports young physician-scientists conducting patient-oriented cancer research.

By VUMC News and Communications
1 2 3